Companies House does not verify the accuracy of the information filed

GILMERTON PHARMA LTD

Company number SC673114

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
04 Feb 2025	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	View PDF Final Gazette dissolved via voluntary strike-off - link opens in a new window - 1 page (1 page)
19 Nov 2024	GAZ1(A)	First Gazette notice for voluntary strike-off	View PDF First Gazette notice for voluntary strike-off - link opens in a new window - 1 page (1 page)
07 Nov 2024	DS01	Application to strike the company off the register	View PDF Application to strike the company off the register - link opens in a new window - 3 pages (3 pages)
18 Sep 2024	CS01	Confirmation statement made on 3 September 2024 with updates	View PDF Confirmation statement made on 3 September 2024 with updates - link opens in a new window - 4 pages (4 pages)
25 Jul 2024	CH01	Director's details changed for Mrs Jennifer Bice Cortellessa on 1 July 2024	View PDF Director's details changed for Mrs Jennifer Bice Cortellessa on 1 July 2024 - link opens in a new window - 2 pages (2 pages)
29 May 2024	AP01	Appointment of Mr Sean Manson as a director on 30 April 2024	View PDF Appointment of Mr Sean Manson as a director on 30 April 2024 - link opens in a new window - 2 pages (2 pages)
17 May 2024	AA	Total exemption full accounts made up to 30 September 2023	View PDF Total exemption full accounts made up to 30 September 2023 - link opens in a new window - 6 pages (6 pages) Download iXBRL
06 Oct 2023	CS01	Confirmation statement made on 3 September 2023 with updates	View PDF Confirmation statement made on 3 September 2023 with updates - link opens in a new window - 4 pages (4 pages)
30 May 2023	TM01	Termination of appointment of Nicholas Ian Johnston as a director on 19 May 2023	View PDF Termination of appointment of Nicholas Ian Johnston as a director on 19 May 2023 - link opens in a new window - 1 page (1 page)
07 Apr 2023	AA	Total exemption full accounts made up to 30 September 2022	View PDF Total exemption full accounts made up to 30 September 2022 - link opens in a new window - 6 pages (6 pages) Download iXBRL
27 Sep 2022	CS01	Confirmation statement made on 3 September 2022 with updates	View PDF Confirmation statement made on 3 September 2022 with updates - link opens in a new window - 5 pages (5 pages)
08 Jul 2022	PSC02	Notification of Blackridge Pharma Ltd as a person with significant control on 6 June 2022	View PDF Notification of Blackridge Pharma Ltd as a person with significant control on 6 June 2022 - link opens in a new window - 2 pages (2 pages)
08 Jul 2022	PSC07	Cessation of Davide Perella as a person with significant control on 6 June 2022	View PDF Cessation of Davide Perella as a person with significant control on 6 June 2022 - link opens in a new window - 1 page (1 page)
08 Jul 2022	PSC07	Cessation of Jennifer Bice Cortellessa as a person with significant control on 6 June 2022	View PDF Cessation of Jennifer Bice Cortellessa as a person with significant control on 6 June 2022 - link opens in a new window - 1 page (1 page)
07 Jun 2022	AA	Total exemption full accounts made up to 30 September 2021	View PDF Total exemption full accounts made up to 30 September 2021 - link opens in a new window - 6 pages (6 pages) Download iXBRL
05 May 2022	AD01	Registered office address changed from Suite 3, Cheviot House Mill Wynd Haddington East Lothian EH41 4EX Scotland to Blackrock House 2-8 Millar Crescent Edinburgh Midlothian EH10 5HW on 5 May 2022	View PDF Registered office address changed from Suite 3, Cheviot House Mill Wynd Haddington East Lothian EH41 4EX Scotland to Blackrock House 2-8 Millar Crescent Edinburgh Midlothian EH10 5HW on 5 May 2022 - link opens in a new window - 1 page (1 page)
07 Oct 2021	CS01	Confirmation statement made on 3 September 2021 with updates	View PDF Confirmation statement made on 3 September 2021 with updates - link opens in a new window - 5 pages (5 pages)
21 Sep 2020	AP01	Appointment of Mr Nicholas Ian Johnston as a director on 21 September 2020	View PDF Appointment of Mr Nicholas Ian Johnston as a director on 21 September 2020 - link opens in a new window - 2 pages (2 pages)
21 Sep 2020	AP01	Appointment of Mr Davide Perella as a director on 21 September 2020	View PDF Appointment of Mr Davide Perella as a director on 21 September 2020 - link opens in a new window - 2 pages (2 pages)
21 Sep 2020	PSC04	Change of details for Ms Jennifer Bice Cortellessa as a person with significant control on 21 September 2020	View PDF Change of details for Ms Jennifer Bice Cortellessa as a person with significant control on 21 September 2020 - link opens in a new window - 2 pages (2 pages)
21 Sep 2020	PSC01	Notification of Davide Perella as a person with significant control on 21 September 2020	View PDF Notification of Davide Perella as a person with significant control on 21 September 2020 - link opens in a new window - 2 pages (2 pages)
04 Sep 2020	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted Statement of capital on 2020-09-04 GBP 1	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted Statement of capital on 2020-09-04 GBP 1 - link opens in a new window - 10 pages (10 pages)

Cookies on Companies House services

GILMERTON PHARMA LTD

Filter by category